Market Overview

Apollo Endosurgery, Inc. to Report Second Quarter Results on August 8, 2018


Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in
less invasive medical devices for bariatric and gastrointestinal
procedures, today announced that the Company is scheduled to release its
financial results for the second quarter ended June 30, 2018 on
Wednesday, August 8, 2018, after the U.S. stock markets close.

Apollo will hold a conference call on Wednesday, August 8, 2018 at 3:30
p.m. CT / 4:30 p.m. ET to discuss the results. The dial-in numbers are
(800) 263-0877 for domestic callers and (646) 828-8143 for international
callers. The conference ID number is 7723529. A live webcast of the
conference call will be available online from the investor relations
page of the Company's corporate website at

A replay of the webcast will remain available on Apollo's website,,
until Apollo releases its third quarter 2018 financial results. In
addition, a telephonic replay of the call will be available until August
15, 2018. The replay dial-in numbers are (844) 512-2921 for domestic
callers and (412) 317-6671 for international callers. Please use the
replay conference ID number 7723529.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less
invasive therapies for the treatment of obesity, a condition facing over
650 million people globally, as well as other gastrointestinal
conditions. Apollo's device based therapies are an alternative to
invasive surgical procedures, thus lowering complication rates and
reducing total healthcare costs. Apollo's products are offered in over
70 countries today and include the OverStitch™ Endoscopic Suturing
System, the ORBERA® Intragastric Balloon, and the LAP-BAND® Adjustable
Gastric Banding System.

Apollo's common stock is traded on NASDAQ Global Market under the symbol
"APEN". For more information regarding Apollo Endosurgery, go to:

View Comments and Join the Discussion!